Renaissance Technologies's BEAM Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 156,500 shares of Beam Therapeutics Inc. (BEAM) worth $4.34 M, representing 0.01% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in BEAM, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 279,900 shares. Largest reduction occurred in Q3 2022, reducing 208,600 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Beam Therapeutics (BEAM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beam Therapeutics (BEAM) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2021 | +38,100 | New Buy | 38,100 | $80.05 |
| Q2 2021 | -21,600 | Reduce 56.69% | 16,500 | $128.73 |
| Q3 2021 | -16,500 | Sold Out | 0 | $0.00 |
| Q2 2022 | +279,900 | New Buy | 279,900 | $38.71 |
| Q3 2022 | -208,600 | Reduce 74.53% | 71,300 | $47.64 |
| Q4 2022 | +60,600 | Add 84.99% | 131,900 | $0.04 |
| Q1 2023 | -131,900 | Sold Out | 0 | $0.00 |
| Q4 2024 | +22,907 | New Buy | 22,907 | $24.80 |
| Q1 2025 | -10,800 | Reduce 47.15% | 12,107 | $19.53 |
| Q2 2025 | -12,107 | Sold Out | 0 | $0.00 |
| Q4 2025 | +156,500 | New Buy | 156,500 | $27.72 |
Renaissance Technologies's Beam Therapeutics Investment FAQs
Renaissance Technologies first purchased Beam Therapeutics Inc. (BEAM) in Q1 2021, acquiring 38,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Beam Therapeutics Inc. (BEAM) for 11 quarters since Q1 2021.
Renaissance Technologies's largest addition to Beam Therapeutics Inc. (BEAM) was in Q2 2022, adding 279,900 shares worth $10.84 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 156,500 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $4.34 M.
As of the Q4 2025 filing, Beam Therapeutics Inc. (BEAM) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Beam Therapeutics Inc. (BEAM) was 279,900 shares, as reported at the end of Q2 2022.